Drawing for NASHVILLE BIOSCIENCES

USPTO serial 87690082

NASHVILLE BIOSCIENCES

Reviewed by CopyMark Law Group

Reg. 5455492Status 701Registered
Filing date
Status date
Registration date
Apr 24, 2018
Examiner
ROSEN, BENJAMIN H
Law office
Historical data usage

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with NASHVILLE BIOSCIENCES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Paige W. Mills

Paige W. Mills Bass, Berry & Sims PLC21 Platform Way South, Suite 3500Nashville, TN 37203United States

Goods and services

ClassDescriptionStatusFirst use
042Biomedical research; Consulting services in the fields of design, planning, and implementation project management of scientific research, medical research and clinical trials; DNA analysis services for scientific research purposes; Drug discovery services; Medical research; Pharmaceutical drug development services; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Scientific investigations for medical purposes; Scientific research and development; Scientific research in the field of healthcare; Scientific study and research in the fields of biochemistry, disease, drug repurposing, drug rescue, genetics, medical diagnostics, medical treatment, personalized medicine, personalized therapeutics, and/or pharmaceuticals; Scientific research and development services based on genomic analyses, and custom consulting services related theretoACTIVENov 19, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 5, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jun 5, 20258.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
May 20, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 28, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 28, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 28, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 27, 2024EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
May 28, 2024PUM1OFFICE ACTION ISSUED POU1—
May 28, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 24, 2024ES8RTEAS SECTION 8 RECEIVED—
Apr 24, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 24, 2018R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Mar 22, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 15, 2018ALIEASSIGNED TO LIE—
Mar 8, 2018CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Mar 8, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Mar 8, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 8, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 8, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 1, 2018DOCKASSIGNED TO EXAMINER—
Dec 1, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 21, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance